Sorrento Therapeutics Inc
OTC:SRNE

Watchlist Manager
Sorrento Therapeutics Inc Logo
Sorrento Therapeutics Inc
OTC:SRNE
Watchlist
Price: 0.0032 USD 18.52% Market Closed
Market Cap: 1.8m USD

Wall Street
Price Targets

SRNE Price Targets Summary
Sorrento Therapeutics Inc

There are no price targets for SRNE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sorrento Therapeutics Inc Competitors:
Price Targets
600161
Beijing Tiantan Biological Products Corp Ltd
48% Upside
ACE
Ascelia Pharma AB
157% Upside
BBIO
BridgeBio Pharma Inc
13% Upside
BVXP
Bioventix PLC
121% Upside
6160
Beigene Ltd
36% Upside
SNDX
Syndax Pharmaceuticals Inc
88% Upside
2696
Shanghai Henlius Biotech Inc
69% Upside
7774
Japan Tissue Engineering Co Ltd
147% Upside

Revenue
Forecast

Revenue Estimate
Sorrento Therapeutics Inc

For the last 11 years the compound annual growth rate for Sorrento Therapeutics Inc's revenue is 55%. The projected CAGR for the next 3 years is 88%.

55%
Past Growth
88%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sorrento Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat

Net Income
Forecast

Net Income Estimate
Sorrento Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-85%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SRNE's stock price target?
Not Available

SRNE doesn't have any price targets made by Wall Street professionals.

What is Sorrento Therapeutics Inc's Revenue forecast?
Projected CAGR
88%

For the last 11 years the compound annual growth rate for Sorrento Therapeutics Inc's revenue is 55%. The projected CAGR for the next 3 years is 88%.

Back to Top